Our study provides a functional annotation to one of the most dysregulated circRNAs in TNBC, suggesting HRD1 and circNR3C2 as the potential prognostic markers and therapeutic targets for patients with triple-negative breast cancer. The gene discussed is SYVN1; the disease is triple-negative breast carcinoma.